Remibrutinib Treatment Improves Itch and Sleep in Chronic Spontaneous Urticaria Patients: Phase 2b Study Results

被引：0

作者：

Hsu, Connie ^{[1
]}

Snyder, Robert ^{[2
]}

Clore, Lee ^{[3
]}

Jain, Vipul ^{[4
]}

Gimenez-Arnau, Ana ^{[5
]}

Lheritier, Karine ^{[6
]}

Walsh, Pauline ^{[7
]}

Haemmerle, Sibylle ^{[6
]}

Wells, Michael ^{[8
]}

Nikolaev, Ivan ^{[6
]}

Maurer, Marcus ^{[9
,10
,11
,12
]}

机构：

[1] Res Solut Arizona, Phoenix, AZ USA

[2] Riverchase Dermatol, Pembroke Pines, FL USA

[3] Allergy & Asthma Specialists PSC, Owensboro, KY USA

[4] McMaster Univ, Div Clin Immunol & Allergy, Dept Med, Hamilton, ON, Canada

[5] Univ Pompeu Fabra, Hosp Mar IMIM, Dept Dermatol, Barcelona, Spain

[6] Novartis Pharma AG, Basel, Switzerland

[7] Novartis Ireland Ltd, Dublin, Ireland

[8] Novartis Pharmaceut, E Hanover, NJ USA

[9] Charit Univ Med Berlin, Inst Allergol, Urticaria Ctr Reference & Excellence UCARE, Berlin, Germany

[10] Free Univ Berlin, Berlin, Germany

[11] Humboldt Univ, Berlin, Germany

[12] Fraunhofer Inst Translatio, Frankfurt, Germany

来源：

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

42939

引用

页码：AB82 / AB82

页数：1